2 October 2024

Howe Street Reporter Title

Tag: Filament Health

  • Today’s Idea: Filament Health’s (FH.NE) psychedelics play

    Today’s Idea: Filament Health’s (FH.NE) psychedelics play

    Our Psychedelic Trip Isn’t Over I don’t know the first thing about psychedelics. Rather, that’s what I would have been saying back in 2020 when the psychedelics sector was experiencing an unprecedented breakout period. Maybe it was because of mainstream media or perhaps it was my nagging parents, but I have always feared psychedelics. Back…

  • Today’s Idea: Filament Health (FH.NE) Is All Natural

    Today’s Idea: Filament Health (FH.NE) Is All Natural

    Natural Talent Albert Hofmann was a fun guy, pun intended. More importantly, the Swiss chemist is known for being the first person to synthesize, consume, and learn of the psychedelic effects of lysergic acid diethylamide (LSD). Truly a mad chemist. Furthermore, Hofmann was also the first person to isolate, synthesize, and name the principal psychedelic compounds…

  • Today’s Idea: Filament Health (FH.NE) Gaining Traction

    Today’s Idea: Filament Health (FH.NE) Gaining Traction

    Problematic Psychedelics? Psychedelics and mental health treatment go together like orange juice and toothpaste. That’s what I would have said five years ago. Prior to the publication of multiple peer-reviewed studies, I adamantly believed psychedelics would melt your brain. In retrospect, that belief is just about as bogus as going to hell for premarital hand-holding.…

  • Filament Health (FH.NEO) is doing the work to stand out in the psychedelics sector

    Filament Health (FH.NEO) is doing the work to stand out in the psychedelics sector

    I’ll admit that I’m beginning to have my suspicions about the psychedelic sector. The question I’ve started asking when I look at a new psychedelics company is where’s the evidence that they’re actually serious about getting products on shelves? How many startup drug companies at will never see the inside of a laboratory? Why? The…

  • If I had a billion dollars: psychedelics sector edition

    If I had a billion dollars: psychedelics sector edition

    The Bare Naked Ladies made “if I had a million dollars,” famous, as they tunefully explained what they would do with their riches. However, in the post-crisis everything bubble, that speculative fantasy no longer bears the same relevance and needs to be ramped up insanely to have any impact. As a thought experiment, let’s pretend…

  • Filament Health (FH.NEO): fighting the good fight against anxiety and depression

    Filament Health (FH.NEO): fighting the good fight against anxiety and depression

    You’d be hard pressed to find someone who hasn’t been touched by depression or anxiety. Biochemically, they’re considered co-morbid, which means they often happen at the same time and feed off of one another. Depression and anxiety often overlap in terms of neurotransmitters and therefore, they’re often lumped together and treated the same way. And…

  • Filament Health (FH.NEO) brings an all natural option to fight depression and anxiety

    Filament Health (FH.NEO) brings an all natural option to fight depression and anxiety

    You’d be hard pressed to find someone who hasn’t been touched by depression or anxiety. Biochemically, they’re considered co-morbid, which means they often happen at the same time and feed off of one another. Depression and anxiety often overlap in terms of neurotransmitters and therefore, they’re often lumped together and treated the same way. And…

  • Filament Health (FN.NEO) – Five Easy Questions with Maddy

    Filament Health (FN.NEO) – Five Easy Questions with Maddy

    Welcome to Five Easy Questions with Maddy Grace where we explain the public markets and the companies that trade on them. In today’s episode, Maddy speaks with Ben Lightburn, CEO of Filament Health, a new psychedelics company with a patented process for extracting compounds naturally and bottling them in consistent dose levels. Enjoy!

  • Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor

    Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor

    Filament Health (FH.NE) to release their unaudited financial results for the second quarter of 2021, a period that ended June 30, 2021. As of June 30, Filament had $7.8 million in cash and cash equivalents. This includes $5 million which was raised through a private placement that closed on June 21. That private placement included…

  • Filament Health (FH.NE): the natural psychedelic company flying under the radar

    Filament Health (FH.NE): the natural psychedelic company flying under the radar

    For the vast majority of the history of human use of psychedelics, they have been seen as something sacred, a gift from God or mother nature herself. Ayahuasca, which contains DMT, was given out by shamans in the Amazon as a tea. It was a spiritual experience that would purge you of your negative energy…